INSP: Wasatch Advisors reports 135,914 shares, 0.5% beneficial stake

Wasatch Advisors LP filed Amendment No. 1 to Schedule 13G for Inspire Medical Systems (INSP), reporting beneficial ownership of 135,914 common shares, representing 0.5% of the class as of September 30, 2025.

Rhea-AI Filing Summary

Wasatch Advisors LP filed Amendment No. 1 to Schedule 13G for Inspire Medical Systems (INSP), reporting beneficial ownership of 135,914 common shares, representing 0.5% of the class as of September 30, 2025.

The firm holds sole voting and sole dispositive power over all reported shares. It certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Wasatch Advisors LP file for INSP?

An Amendment No. 1 to Schedule 13G reporting its beneficial ownership in Inspire Medical Systems.

How many INSP shares does Wasatch Advisors report owning?

Wasatch reports 135,914 common shares beneficially owned.

What percentage of INSP does this represent?

The filing states a 0.5% beneficial ownership of the class.

What are Wasatch’s voting and dispositive powers over these shares?

Wasatch has sole voting power over 135,914 shares and sole dispositive power over 135,914 shares; no shared power is reported.

What is the date of the event requiring the filing?

The filing lists September 30, 2025 as the event date.

How is Wasatch Advisors classified in the filing?

The reporting person is classified as IA (Investment Adviser).

Does the filing indicate any intent to influence control of INSP?

No. It certifies the securities are held in the ordinary course of business and not to influence control.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 01:38 PM EST Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Inspire Medical Systems Inc

(Name of Issuer)

COM

(Title of Class of Securities)

457730109

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 457730109

1

Names of Reporting Persons

Wasatch Advisors LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 135,914.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 135,914.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

135,914.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.5 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Inspire Medical Systems Inc
(b)	Address of issuer's principal executive offices: 5500 Wayzata Boulevard, Suite 1600, Golden Valley, US-MN, 55416, US
Item 2.
(a)	Name of person filing: Wasatch Advisors LP
(b)	Address or principal business office or, if none, residence: 505 Wakara Way, 3rd Floor, Salt Lake City, 84108, United States
(c)	Citizenship: DELAWARE
(d)	Title of class of securities: COM
(e)	CUSIP No.: 457730109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 135,914
(b)	Percent of class: 0.5 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 135,914
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 135,914
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Wasatch Advisors LP

Signature:	Mike Yeates
Name/Title:	CEO
Date:	11/12/2025